Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
62.7M
-
Shares change
-
+2.21K
-
Total reported value, excl. options
-
$3.96B
-
Value change
-
+$29M
-
Put/Call ratio
-
2.6
-
Number of buys
-
100
-
Number of sells
-
-100
-
Price
-
$63.20
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2023
258 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2023.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.7M shares
.
Largest 10 shareholders include FMR LLC (6.71M shares), BlackRock Inc. (6.54M shares), VANGUARD GROUP INC (5.93M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.62M shares), WELLINGTON MANAGEMENT GROUP LLP (4.92M shares), STATE STREET CORP (2.5M shares), T. Rowe Price Investment Management, Inc. (2.45M shares), Rock Springs Capital Management LP (2.19M shares), EcoR1 Capital, LLC (1.8M shares), and ALLIANCEBERNSTEIN L.P. (1.61M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.